We have noticed a number of questions concerning how GeneTx is funded and specifically who pays for the salaries of the GeneTx employees. We understand
INSYNC-AS: A collaboration between FAST and the Simons Foundation Autism Research Initiative (SFARI) The Foundation for Angelman Syndrome Therapeutics (FAST) is here to demonstrate our
IAD is an opportunity to raise awareness and raise funds towards a cure for Angelman syndrome. FAST has made that easier by providing a few resources:
The 2020 FAST Global Virtual Summit & mini-Gala, Virtually Unstoppable, was a truly incredible virtual experience that took place December 4-5, 2020. Over 1,700 people from 61 countries around the world joined in the two-day virtual event. FAST’s amazing community raised $2.2 million in pursuit of the mission to #CureAngelmanNow. Catch up on 2020’s best moments, announcements, and sessions below. We look forward to being together again in 2021 – Save the Date: December 3-4, 2021.